Simulations Plus, Inc. announced that it has released version 10.3 of its machine learning modeling platform, ADMET Predictor®. The new release will be marketed as APX.3. Key enhancements in APX.3 include: New capabilities in the Artificial Intelligence-driven Drug Design (AIDD) Module to incorporate calculations from any third-party program for use in compound optimization expanding client’s existing toolbox. Major update to CYP metabolism models with a new knowledgebase that significantly expands the addressable chemical coverage space. Access to MedChem Studio™ extended to all users to provide high-quality data visualization, compound clustering, and high throughput screening analysis functionality to enhance data analytics capabilities for general use. New REST API for deployment via Web services.